in a previous clinical study a probiotic formulation pf consisting of lactobacillus helveticus r0052 and bifidobacterium longum r0175 pf decreased stressinduced gastrointestinal discomfortemerging evidence of a role for gut microbiota on central nervous system functions therefore suggests that oral intake of probiotics may have beneficial consequences on mood and psychological distressthe aim of the present study was to investigate the anxiolyticlike activity of pf in rats and its possible effects on anxiety depression stress and coping strategies in healthy human volunteersin the preclinical study rats were daily administered pf for 2 weeks and subsequently tested in the conditioned defensive burying test a screening model for antianxiety agentsin the clinical trial volunteers participated in a doubleblind placebocontrolled randomised parallel group study with pf administered for 30 d and assessed with the hopkins symptom checklist hscl90 the hospital anxiety and depression scale hads the perceived stress scale the coping checklist ccl and 24 h urinary free cortisol ufcdaily subchronic administration of pf significantly reduced anxietylike behaviour in rats p  005 and alleviated psychological distress in volunteers as measured particularly by the hscl90 scale global severity index p  005 somatisation p  005 depression p  005 and angerhostility p  005 the hads hads global score p  005 and hadsanxiety p  006 and by the ccl problem solving p  005 and the ufc level p  005l helveticus r0052 and b longum r0175 taken in combination display anxiolyticlike activity in rats and beneficial psychological effects in healthy human volunteers